Stockadora

8-K filings / November 18, 2026

ACCENDRA HEALTH INC/VA/: A stock exchange listing notice

ACCENDRA HEALTH INC/VA/ filed a current report (Form 8-K) with the SEC on November 18, 2026. It reports a stock exchange listing notice.

AI-written from the facts below

In plain English

On November 16, 2026, the company received a notice from the New York Stock Exchange regarding its stock exchange listing. The notice reports a delisting decision by the exchange, or a step in a hearing on delisting, and cites Section 802.01D.

What each sentence states
“On November 16, 2026, the company received a notice from the New York Stock Exchange regarding its stock exchange listing.”
  • Item 3.01 of Form 8-K covers notices about a company's stock exchange listing.
  • Item 3.01: the exchange is the New York Stock Exchange.
  • Item 3.01: the company received the exchange's notice on November 16, 2026.
“The notice reports a delisting decision by the exchange, or a step in a hearing on delisting, and cites Section 802.01D.”
  • Item 3.01: what it reports: a delisting decision by the exchange, or a step in a hearing on delisting.
  • Item 3.01: the rule cited is Section 802.01D.
Written by an AI model from the facts on this page only; code and a second model checked every sentence against them.

Item 3.01

Stock exchange listing notice

  • Exchange New York Stock Exchange From the filing
    Source
    “On November 16, 2026, Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (“NYSE”) Regulation that it has suspended trading of the Company’s common stock and determined to commence proceedings to delist the Company’s common stock from the NYSE.”
    Read by code from this sentence of the filing.
  • What it says A decision to delist, or a step in the hearing on it From the filing
    Source
    “On November 16, 2026, Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (“NYSE”) Regulation that it has suspended trading of the Company’s common stock and determined to commence proceedings to delist the Company’s common stock from the NYSE.”
    Read by code from this sentence of the filing.
  • Rule cited Section 802.01D From the filing
    Source
    “The NYSE Regulation determined that the Company’s common stock is no longer suitable for listing based on abnormally low selling price levels, pursuant to Section 802.01D of the NYSE Listed Company Manual.”
    Read by code from this sentence of the filing.
  • Notice date November 16, 2026 From the filing
    Source
    “On November 16, 2026, Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (“NYSE”) Regulation that it has suspended trading of the Company’s common stock and determined to commence proceedings to delist the Company’s common stock from the NYSE.”
    Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov

Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.